Alterations of 3p21.31 tumor suppressor genes in head and neck squamous cell carcinoma: Correlation with progression and prognosis

被引:44
作者
Ghosh, Susumita [1 ]
Ghosh, Amlan [1 ]
Maiti, Guru Prasad [1 ]
Alam, Neyaz [2 ]
Roy, Anup [3 ]
Roy, Bidyut [4 ]
Roychoudhary, Susanta [5 ]
Panda, Chinmay Kumar [1 ]
机构
[1] Chittaranjan Natl Canc Inst, Dept Oncogene Regulat, Kolkata 700026, India
[2] Chittaranjan Natl Canc Inst, Dept Surg, Kolkata, India
[3] Calcutta Med Coll & Hosp, Kolkata, India
[4] Indian Stat Inst, Human Genet Unit, Kolkata, India
[5] Indian Inst Chem Biol, Mol & Human Genet & Genom Div, Kolkata, India
关键词
dysplastic lesions; expression; head and neck squamous cell carcinoma; mutation; 3p21.31; survival study; tumor suppressor genes; methylation;
D O I
10.1002/ijc.23834
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of our study, was to analyze the alterations of some candidate tumor suppressor genes (TSGs) viz. LIMD1, LTF. CDC25A, SCOTIN, RASSFIA anti CACNA2D2 located in the chromosomal region 3p21.31 associated with the development of early dysplastic lesions of head and neck. In analysis of 72 dysplastic lesions anti 116 squamous cell carcinoma of head and neck. both deletion and promoter methylation have been seen in these genes except for CDC25A anti SCOTIN where no methylation has been detected. The alteration of LIMDI was highest (50%) in the mild dysplastic lesions and did not change significantly during progression of tumor indicating its association with this stage of the disease. It was evident that alterations of LTF, CDC25A and CACNA2D2 were associated with development of moderate dysplastic lesions, while alterations in RASSFIA and CACNA2D2 were needed for progression. Novel somatic mutations were seen in exon 1 of LIMDI (7%). intron 3/exon4 splice,junction of LTF (2%) and exon 7 of cdc25A (10%). Quantitative RT-PCR analysis revealed mean reduced expression of the genes in the order: LTF (67.6 +/- 16.8) > LIMDI (53.2 +/- 20.1) > CACNA2D2 (23.7 +/- 7.1) > RASSFIA (15.1 +/- 5.6) > CDC25A (5.3 +/- 2.3) > SCOTIN (0.58 +/- 0.54). Immunohistochemical analysis of CDC25A showed its localization both in cytoplasm and nucleus in primary lesions and oral cancer cell lines. In absence of HPN infection, LTF and RASSFIA alterations jointly have adverse impact on survival of tobacco addicted patients. Thus, our data suggested that multiple candidate TSGs in the chromosomal 3p21.31 region were differentially associated with the early dysplastic lesions of head anti neck. (C) 2008 Wiley-Liss, Inc.
引用
收藏
页码:2594 / 2604
页数:11
相关论文
共 57 条
[11]  
Dalal SN, 1999, MOL CELL BIOL, V19, P4465
[12]  
Dallol A, 2002, CANCER RES, V62, P5874
[13]  
Dammann R, 2005, HISTOL HISTOPATHOL, V20, P645, DOI 10.14670/HH-20.645
[14]   Mapping of the candidate tumor suppressor genes' loci on human chromosome 3 in head and neck squamous cell carcinoma of an Indian patient population [J].
Dasgupta, S ;
Mukherjee, N ;
Roy, S ;
Roy, A ;
Sengupta, A ;
Roychowdhury, S ;
Panda, CK .
ORAL ONCOLOGY, 2002, 38 (01) :6-15
[15]  
Dong SM, 2003, CLIN CANCER RES, V9, P3635
[16]   The LIM protein, LIMD1, regulates AP-1 activation through an interaction with TRAF6 to influence osteoclast development [J].
Feng, Yunfeng ;
Zhao, Haibo ;
Luderer, Hilary F. ;
Epple, Holly ;
Faccio, Roberta ;
Ross, F. Patrick ;
Teitelbaum, Steven L. ;
Longmore, Gregory D. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (01) :39-48
[17]   HYAL1LUCA-1, a candidate tumor suppressor gene on chromosome 3p21.3, is inactivated in head and neck squamous cell carcinomas by aberrant splicing of pre-mRNA [J].
Frost, GI ;
Mohapatra, G ;
Wong, TM ;
Csóka, AB ;
Gray, JW ;
Stern, R .
ONCOGENE, 2000, 19 (07) :870-877
[18]   RAF1 INTERACTION WITH CDC25 PHOSPHATASE TIES MITOGENIC SIGNAL-TRANSDUCTION TO CELL-CYCLE ACTIVATION [J].
GALAKTIONOV, K ;
JESSUS, C ;
BEACH, D .
GENES & DEVELOPMENT, 1995, 9 (09) :1046-1058
[19]   CDC25 PHOSPHATASES AS POTENTIAL HUMAN ONCOGENES [J].
GALAKTIONOV, K ;
LEE, AK ;
ECKSTEIN, J ;
DRAETTA, G ;
MECKLER, J ;
LODA, M ;
BEACH, D .
SCIENCE, 1995, 269 (5230) :1575-1577
[20]  
Gasparotto D, 1997, CANCER RES, V57, P2366